PMAIP1 and neoplasm: Together, the results of the present study show that apigenin could upregulate Noxa expression by inhibiting the AKT-FoxO3a signaling pathway, thereby synergizing with ABT-263 to exert antitumor effects in EGFRm tumor cells.